Capricor Therapeutics
Price & Volume
Stats
See more52W Range | $4.30-$40.37 |
Market Cap | $1.7B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $11.1M |
Revenue Growth (YoY) | -7.9% |
Gross Profit (12 Mos) | -$92.9M |
Diluted EPS | -$2.32 |
News
See moreYahoo Finance • 24 days ago
Challenges in Online Sales Hurt FitLife Brands (FTLF) in Q1
Yahoo Finance • 2 months ago
After-Hours Earnings Report for May 12, 2026 : FNV, NXT, OKLO, KRMN, REZI, ATRO, CAPR, AIP, EVLV, KURA, RLMD, GAIN
Yahoo Finance • 2 months ago
Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story
Yahoo Finance • 4 months ago
Capricor signals potential commercialization of Deramiocel with $318M cash balance and FDA review milestone
About
CEO | Dr. Linda Marbán Ph.D. |
CFO | Mr. Anthony J. Bergmann M.B.A. |
Address | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 231 |